Literature DB >> 9685911

Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.

C Evora1, I Soriano, R A Rogers, K N Shakesheff, J Hanes, R Langer.   

Abstract

This study examines the potential of 1,2-dipalmitoylphosphatidylcholine (DPPC), a major component of lung surfactant, to reduce the phagocytosis of microspheres by altering the cellular interactions occurring in the alveoli. These microspheres could be designed to act as a controlled delivery system for small molecules, peptides or proteins for pulmonary administration. Microspheres were prepared using poly (lactic-co-glycolic acid) (PLGA, 50/50 and encapsulated peroxidase as a model protein. DPPC was included in some formulations. The interaction of PLGA and DPPC-PLGA microspheres with phagocytic cells was evaluated using lung macrophages in culture. X-ray Photoelectron Spectra (XPS) results indicate that the inclusion of DPPC in the microspheres alters the microsphere surface chemistry, with the DPPC covering a large portion of the microsphere surface. The dominance of DPPC on the microsphere surface is highly beneficial in moderating the interaction occurring between the microspheres and phagocytic cells in the lung. Fluorescent confocal microscopy indicates that only 25% of cells internalized DPPC-coated particles, whereas 70% of those cells exposed to particles without the DPPC coating internalized particles after one hour of incubation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685911     DOI: 10.1016/s0168-3659(97)00149-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  26 in total

1.  Cationic microparticles: A potent delivery system for DNA vaccines.

Authors:  M Singh; M Briones; G Ott; D O'Hagan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Sustained release drug delivery to the lungs: an option for the future.

Authors:  J G Hardy; T S Chadwick
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

3.  Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine.

Authors:  A I Bot; D J Smith; S Bot; L Dellamary; T E Tarara; S Harders; W Phillips; J G Weers; C M Woods
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Precise control of PLG microsphere size provides enhanced control of drug release rate.

Authors:  Cory Berkland; Martin King; Amanda Cox; Kyekyoon Kim; Daniel W Pack
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

Review 5.  Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.

Authors:  Lauren Willis; Don Hayes; Heidi M Mansour
Journal:  Lung       Date:  2012-01-25       Impact factor: 2.584

6.  In vivo particle uptake by airway macrophages in healthy volunteers.

Authors:  Neil E Alexis; John C Lay; Kirby L Zeman; Marianne Geiser; Nadine Kapp; William D Bennett
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-04       Impact factor: 6.914

Review 7.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

8.  Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes.

Authors:  Qiu Zhong; Dakshina Murthy Devanga Chinta; Sarala Pamujula; Haifan Wang; Xin Yao; Tarun K Mandal; Ronald B Luftig
Journal:  J Nanobiotechnology       Date:  2010-02-24       Impact factor: 10.435

9.  Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.

Authors:  Tammy W Shen; Catherine A Fromen; Marc P Kai; J Christopher Luft; Tojan B Rahhal; Gregory R Robbins; Joseph M DeSimone
Journal:  Pharm Res       Date:  2015-05-23       Impact factor: 4.200

Review 10.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.